Company Expanding Market Penetration in Latin America with Partner, ilender Corp.
Research Triangle Park, N.C. / Lima, Peru — January 19, 2016— BioResource International, Inc. (BRI), a global biotechnology company specializing in the research, development and manufacture of high-performance enzyme feed additives for animal nutrition, announced today it has received regulatory approval of its proprietary xylanase feed additive, XylamaxTM, for use in Brazil and Peru. Regulatory approval is in process for additional Latin American countries, expanding the worldwide Xylamax market to include South America, Central America and South Asia.
Xylamax will be marketed to poultry producers, feed integrators and animal health and nutrition consultants under the enerxyme brand by BRI’s distribution partner, ilender Corp., beginning in the first quarter of 2016. Enerxyme was designed and developed in BRI’s Research Triangle headquarters in Durham, NC, USA. Enerxyme is tested in the USA using rigorous scientific methodologies that comply with leading international quality standards, to ensure consistent product quality and safety.
According to the Brazilian Association of Animal Protein (ABPA), chicken production in Brazil is now close to that of China, the world’s second largest producer. Although Peru’s chicken production is much smaller than that of Brazil, the Peruvian Poultry Association (APA) states that it has increased 94% in the last decade and is projected to continue increasing at approximately 8% per year.
Enerxyme sales in Latin America will be led by the ilender team in coordination with Cliff Hsun, BRI Director of Global Sales. Mr. Hsun has considerable experience building and managing sales and marketing for animal feed suppliers in Latin American markets, including Bolivia, Chile, Ecuador, Peru, Venezuela, Argentina and Costa Rica.
“The size of the Latin American poultry production market and its projected future growth make the region an important expansion opportunity for BRI. We are particularly pleased to have someone with Cliff’s experience supporting ilender and their customers,” said Julian Young, Chief Operating Officer, BRI.
“There is growing interest among our customers and partners throughout Latin America regarding enzyme feed additives that can optimize animal nutrition and performance,” commented Sergio Gamio, General Manager ilender Corp. “We are quite optimistic about the potential for enerxyme in Brazil and Peru as well as other countries in the region.”
Founded in 1999, BRI is a global biotechnology company specializing in the research, development and manufacture of high-performance enzyme feed additives that help poultry and swine producers optimize animal nutrition. BRI products are effective tools for managing rising feed costs and feed ingredient quality variations in a way that is safe for animals, humans and the environment. The company has earned a reputation as a team of trusted enzyme experts who utilize their scientific expertise to create innovative products that solve nutritional and sustainability challenges facing meat producers around the world. For more information, please visit http://briworldwide.com/.
Ilender is a multinational corporation with headquarters in Lima, Peru serving the pharmaceutical and food additive needs of the animal feed industry. With over 25 years of service, ilender has a presence in 15 countries and is supported by a significant network of business partners, universities and research institutes throughout Latin America and around the world. ilender’s products are designed with a commitment to social development, resource sustainability and innovation. All ilender products are developed and tested to comply with stringent global quality and safety standards, including GMP and ISO 9001. For more information on ilender, please visit http://ilendercorp.com/